Perforated tissue matrix
US-2024408277-A1 · Dec 12, 2024 · US
US9028857B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9028857-B2 |
| Application number | US-68167608-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 10, 2008 |
| Priority date | Oct 11, 2007 |
| Publication date | May 12, 2015 |
| Grant date | May 12, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide and one cross-linking agent b) freezing the aqueous solution of step a) c) sublimating the frozen solution of step b). characterized in that step b) is performed before the cross-linking of the polysaccharide occurs in the solution of step a).
Opening claim text (preview).
The invention claimed is: 1. A method for preparing a porous scaffold consisting of the steps of a) preparing an alkaline aqueous solution consisting of an amount of at least one natural polysaccharide and one cross-linking agent; b) freezing the aqueous solution of step a); and c) sublimating the frozen solution of step b); wherein the at least one natural polysaccharide is selected from the group consisting of dextran, agar, alginic acid, hyaluronic acid, inulin, pullulan, heparin, chitonsan, and fucoidan; and wherein step b) is performed before the cross-linking of the natural polysaccharide and said cross-linking occurs during the sublimation step c). 2. The method according to claim 1 wherein said cross-linking agent is selected in the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl3), eupichlorohydrin, formaldehydes, water soluble carbodiimides, and glutaraldehydes. 3. The method according to claim 2 wherein said cross-linking agent is trisodium trimetaphosphate (STMP). 4. The method according to claim 1 wherein the aqueous solution of step a) is freeze-dried. 5. The method according to claim 4 wherein the aqueous solution of step a) is freeze-dried under a pressure from 0.1 mBar to 6.5 mBar. 6. The method according to claim 1 wherein the aqueous solution of step a) is poured in a mould before step b). 7. The method according to claim 1 wherein said scaffold is shaped.
Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.] · CPC title
the carrier being a carbohydrate · CPC title
Crosslinking, e.g. vulcanising, of macromolecules (mechanical aspects B29C35/00; crosslinking agents C08K) · CPC title
for cartilage reconstruction, e.g. meniscus · CPC title
Acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.